New treatment helps achieve a healthier BMI in people with weight dysregulation after brain tumors

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found.

The results of the trial have been published in the New England Journal of Medicine.

The new drug, setmelanotide, offers hope for improved health and quality of life for children and adults with hormonal and metabolic dysfunction caused by a brain tumor. ...